Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramod Kuchulakanti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Invasive Cardiology|December 9, 2003
Repeat radiation for recurrent in-stent restenosis in patients who failed initial brachytherapyPramod Kuchulakanti, Ron Waksman
Drugs|October 16, 2004
Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosisPramod Kuchulakanti, Ron Waksman
The Journal of Invasive Cardiology|June 5, 2003
Mechanisms and methods to resolve edge effectPramod Kuchulakanti, Robert Lew, Ron Waksman, et al.
Cardiovascular Radiation Medicine|October 7, 2004
Peroxisome proliferator-activated receptor gamma: its role in metabolic syndromeRajbabu Pakala, Pramod Kuchulakanti, Seung-Woon Rha, et al.
American Heart Journal|October 8, 2005
Brachytherapy and bivalirudin evaluation studyPramod Kuchulakanti, Roswitha Wolfram, Rebecca Torguson, et al.
The American Journal of Cardiology|May 29, 2004
Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosisPramod Kuchulakanti, Seung-Woon Rha, Lowell F Satler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 9, 2005
Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosisPramod Kuchulakanti, Rebecca Torguson, Daniel Canos, et al.
The Journal of Invasive Cardiology|December 15, 2004
Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patientsPramod Kuchulakanti, Seung-Woon Rha, Lowell F Satler, et al.
The Journal of Invasive Cardiology|January 11, 2005
Impact of continued hospitalization in patients pre-treated with clopidogrel prior to coronary angiography and undergoing coronary artery bypass graftingPramod Kuchulakanti, Emmanouil I Kapetanakis, Robert Lew, et al.
Journal of the American College of Cardiology|October 7, 2004
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) studyRon Waksman, Andrew E Ajani, Augusto D Pichard, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Invasive Cardiology|December 9, 2003
Repeat radiation for recurrent in-stent restenosis in patients who failed initial brachytherapyPramod Kuchulakanti, Ron Waksman
Drugs|October 16, 2004
Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosisPramod Kuchulakanti, Ron Waksman
The Journal of Invasive Cardiology|June 5, 2003
Mechanisms and methods to resolve edge effectPramod Kuchulakanti, Robert Lew, Ron Waksman, et al.
Cardiovascular Radiation Medicine|October 7, 2004
Peroxisome proliferator-activated receptor gamma: its role in metabolic syndromeRajbabu Pakala, Pramod Kuchulakanti, Seung-Woon Rha, et al.
American Heart Journal|October 8, 2005
Brachytherapy and bivalirudin evaluation studyPramod Kuchulakanti, Roswitha Wolfram, Rebecca Torguson, et al.
The American Journal of Cardiology|May 29, 2004
Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosisPramod Kuchulakanti, Seung-Woon Rha, Lowell F Satler, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 9, 2005
Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosisPramod Kuchulakanti, Rebecca Torguson, Daniel Canos, et al.
The Journal of Invasive Cardiology|December 15, 2004
Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patientsPramod Kuchulakanti, Seung-Woon Rha, Lowell F Satler, et al.
The Journal of Invasive Cardiology|January 11, 2005
Impact of continued hospitalization in patients pre-treated with clopidogrel prior to coronary angiography and undergoing coronary artery bypass graftingPramod Kuchulakanti, Emmanouil I Kapetanakis, Robert Lew, et al.
Journal of the American College of Cardiology|October 7, 2004
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) studyRon Waksman, Andrew E Ajani, Augusto D Pichard, et al.
Pageof 2